Patents by Inventor Xin-Xing Gu

Xin-Xing Gu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Intranasal immunization with detoxified lipooligosaccharide from nontypeable or
    Patent number: 7641906
    Abstract: The invention relates to intranasal immunization with detoxified lipooligosaccharide from nontypeable Haemophilus influenzae or Moraxella catarrhalis.
    Type: Grant
    Filed: October 27, 2005
    Date of Patent: January 5, 2010
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventor: Xin-Xing Gu
  • Peptide mimotopes of lipooligosaccharide from nontypeable Haemophilus influenzae as vaccines
    Patent number: 7514529
    Abstract: The present invention relates to peptide mimotopes of lipooligosaccharide from nontypeable Haemophilus influenzae as vaccines.
    Type: Grant
    Filed: July 22, 2005
    Date of Patent: April 7, 2009
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventor: Xin-Xing Gu
  • Intranasal immunization with detoxified lipooligosaccharide from nontypeable Haemophilus influenzae or Moraxella catarrhalis
    Publication number: 20060062741
    Abstract: The invention relates to intranasal immunization with detoxified lipooligosaccharide from nontypeable Haemophilus influenzae or Moraxella catarrhalis.
    Type: Application
    Filed: October 27, 2005
    Publication date: March 23, 2006
    Inventor: Xin-Xing Gu
  • Peptide mimotopes of lipooligosaccharide from nontypeable Haemophilus influenzae as vaccines
    Publication number: 20060018919
    Abstract: The present invention relates to peptide mimotopes of lipooligosaccharide from nontypeable Haemophilus influenzae as vaccines.
    Type: Application
    Filed: July 22, 2005
    Publication date: January 26, 2006
    Inventor: Xin-Xing Gu
  • Intranasal immunization with detoxified lipooligosaccharide from nontypeable haemophilus influenzae or moraxella
    Publication number: 20040126381
    Abstract: The invention relates to intranasal immunization with detoxified lipooligosaccharide from nontypeable Haemophilus influenzae or Moraxella catarrhalis.
    Type: Application
    Filed: October 17, 2003
    Publication date: July 1, 2004
    Inventor: Xin-Xing Gu
  • Lipooligosaccharide-based vaccine for prevention of Moraxella (Branhamella) catarrhalis infections in humans
    Publication number: 20040115214
    Abstract: A conjugate vaccine for Moraxella (Branhamella) catarrhalis comprising isolated lipooligosaccharide from which esterified fatty acids have been removed, to produce a detoxified lipooligosaccharide (dLOS), or from which lipid A has been removed, to produce a detoxified oligosaccharide (OS), which is linked to an immunogenic carrier. The vaccine is useful for preventing otitis media and respiratory infections caused by M. catarrhalis in mammals, including humans.
    Type: Application
    Filed: December 5, 2003
    Publication date: June 17, 2004
    Inventors: Xin-Xing Gu, John B. Robbins
  • Lipooligosaccharide based vaccine for prevention of moraxella (branhamella)catarrhalis infections in humans
    Patent number: 6685949
    Abstract: A conjugate vaccine for Moraxella (Branhamella) catarrhalis comprising isolated lipooligosaccharide from which esterified fatty acids have been removed, to produce a detoxified lipooligosaccharide (dLOS), or from which lipid A has been removed, to produce a detoxified oligosaccharide (OS), which is linked to an immunogenic carrier. The vaccine is useful for preventing otitis media and respiratory infections caused by M. catarrhalis in mammals, including humans.
    Type: Grant
    Filed: July 5, 2000
    Date of Patent: February 3, 2004
    Assignee: The United States of America as represented by the Department of Health & Human Services
    Inventors: Xin-Xing Gu, John B. Robbins
  • Conjugate vaccine for nontypeable Haemophilus influenzae
    Patent number: 6607725
    Abstract: A conjugate vaccine for Nontypeable Haemophilus influenzae comprising lipooligosaccharide from which esterified fatty acids have been removed conjugated to an immunogenic carrier. The vaccine is useful for prevention of otitis media and respiratory infections in mammals.
    Type: Grant
    Filed: February 20, 2001
    Date of Patent: August 19, 2003
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Xin-Xing Gu, Chao-Ming Tsai, David J. Lim, John B. Robbins
  • Conjugate vaccine for Neisseria meningitidis
    Patent number: 6531131
    Abstract: A conjugate vaccine for Neisseria meningitidis comprising lipooligosaccharide which does not contain a lacto-N-tetraose antigen from which at least one primary O-linked fatty acid has been removed conjugated to an immunogenic carrier. The vaccine is useful for prevention of meningitis and septic shock in mammals.
    Type: Grant
    Filed: July 26, 2000
    Date of Patent: March 11, 2003
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Xin-Xing Gu, Chao-Ming Tsai
  • Conjugate vaccine for nontypeable haemophilus influenzae
    Publication number: 20020001589
    Abstract: A conjugate vaccine for Nontypeable Haemophilus influenzae comprising lipooligosaccharide from which esterified fatty acids have been removed conjugated to an immunogenic carrier. The vaccine is useful for prevention of otitis media and respiratory infections in mammals.
    Type: Application
    Filed: February 20, 2001
    Publication date: January 3, 2002
    Inventors: Xin-Xing Gu, Chao-Ming Tsai, David J. Lim, John B. Robbins
  • Conjugate vaccine for nontypeable Haemophilus influenzae
    Patent number: 6207157
    Abstract: A conjugate vaccine for Nontypeable Haemophilus influenzae comprising lipooligosaccharide from which esterified fatty acids have been removed conjugated to an immunogenic carrier. The vaccine is useful for prevention of otitis media and respiratory infections in mammals.
    Type: Grant
    Filed: April 23, 1997
    Date of Patent: March 27, 2001
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Xin-Xing Gu, Chao-Ming Tsai, David J. Lim, John B. Robbins